Header Logo

Connection

Javid Fazili to Humans

Back to Details
This is a "connection" page, showing publications Javid Fazili has written about Humans.
Javid Fazili
Connection Strength
0.179
Humans
  1. Spontaneous Intramural Esophageal Hematoma. Clin Gastroenterol Hepatol. 2018 02; 16(2):e19-e20.
    View in: PubMed
    Score: 0.032
  2. Outcome of a hepatitis C outbreak among patients in a pain management clinic. Dig Dis Sci. 2010 Jun; 55(6):1738-43.
    View in: PubMed
    Score: 0.020
  3. A case of hearing loss associated with pegylated interferon and ribavirin treatment ameliorated by prednisone. Nat Clin Pract Gastroenterol Hepatol. 2009 Jan; 6(1):57-60.
    View in: PubMed
    Score: 0.018
  4. Treating acute hepatitis B. Hepatology. 2007 Aug; 46(2):607-8; author reply 608.
    View in: PubMed
    Score: 0.016
  5. From Inflammation to Oncogenesis: Tracing Serum DCLK1 and miRNA Signatures in Chronic Liver Diseases. Int J Mol Sci. 2024 Jun 12; 25(12).
    View in: PubMed
    Score: 0.013
  6. How gastroenterologists inform patients of results after lower endoscopy. Am J Gastroenterol. 2001 Jul; 96(7):2086-92.
    View in: PubMed
    Score: 0.011
  7. Doublecortin-like kinase 1 promotes hepatocyte clonogenicity and oncogenic programming via non-canonical ß-catenin-dependent mechanism. Sci Rep. 2020 06 29; 10(1):10578.
    View in: PubMed
    Score: 0.010
  8. Impact of sustained virologic response on short-term clinical outcomes in hepatitis C-related cirrhosis. Eur J Gastroenterol Hepatol. 2018 Mar; 30(3):296-301.
    View in: PubMed
    Score: 0.009
  9. Gastric heterotopia in the rectum. A rare cause of ectopic gastric tissue. Arab J Gastroenterol. 2017 Mar; 18(1):42-43.
    View in: PubMed
    Score: 0.008
  10. Plasma DCLK1 is a marker of hepatocellular carcinoma (HCC): Targeting DCLK1 prevents HCC tumor xenograft growth via a microRNA-dependent mechanism. Oncotarget. 2015 Nov 10; 6(35):37200-15.
    View in: PubMed
    Score: 0.007
  11. Cirrhosis and its complications: evidence based treatment. World J Gastroenterol. 2014 May 14; 20(18):5442-60.
    View in: PubMed
    Score: 0.007
  12. A randomized controlled trial adding fluvastatin to peginterferon and ribavirin for naïve genotype 1 hepatitis C patients. J Viral Hepat. 2013 Sep; 20(9):622-7.
    View in: PubMed
    Score: 0.006
  13. Optimizing chemotherapy: concomitant medication lists. Clin Pharmacol Ther. 2011 Jan; 89(1):114-9.
    View in: PubMed
    Score: 0.005
  14. Hepatitis C prevalence in patients with hepatocellular carcinoma without cirrhosis. Am J Med Sci. 2010 Feb; 339(2):169-73.
    View in: PubMed
    Score: 0.005
  15. Fluvastatin inhibits hepatitis C replication in humans. Am J Gastroenterol. 2008 Jun; 103(6):1383-9.
    View in: PubMed
    Score: 0.004
  16. Remission of natural-killer cell lymphoma of the liver with anti-hepatitis C therapy. Am J Hematol. 2005 Mar; 78(3):212-5.
    View in: PubMed
    Score: 0.003
  17. Development and validation of a model to diagnose cirrhosis in patients with hepatitis C. Am J Gastroenterol. 2002 Oct; 97(10):2623-8.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.